Evaluation of liver samples from patients with NASH and in FPC-fed mice revealed an inverse correlation between liver Creld2 and lipogenesis gene Fasn. Selective targeting of liver CRELD2 via AAV8-shCreld2 in mice confirmed this relationship in an acute model of dyslipidemia. Here, FASN is linked to metabolic dysfunction-associated steatohepatitis.